Analysis: Bayer bets on `silver bullet` defense in Roundup litigation; experts see hurdles
(Independent.ie Business)

Bayer AG plans to argue that a $2 billion jury award and thousands of U.S. lawsuits claiming its glyphosate-based weed killer Roundup causes cancer should be tossed because a U.S. regulatory agency said the herbicide is not a public health risk.